NIFTY23,3610.19%
SENSEX74,1510.26%
BANKNIFTY54,0590.23%
NIFTY IT29,3120.25%
PHARMA24,1720.36%
AUTO26,2650.66%
FMCG48,2060.17%
METAL13,4350.74%
REALTY766.600.52%
ENERGY40,4560.64%
NIFTY23,3610.19%
SENSEX74,1510.26%
BANKNIFTY54,0590.23%
NIFTY IT29,3120.25%
PHARMA24,1720.36%
AUTO26,2650.66%
FMCG48,2060.17%
METAL13,4350.74%
REALTY766.600.52%
ENERGY40,4560.64%

Rajesh Exports Denies Allegations, Cites Interim Order as Unfounded

Rajesh Exports, a leading jewellery exporting firm, has responded to the interim order passed by the Securities and Exchange Board of India (SEBI) on June 3. The market regulator had alleged financial misrepresentation, fund-routing irregularities, and non-cooperation during an ongoing investigation against Rajesh Exports Ltd. (REL) and its chairman and managing director, Rajesh Mehta.

According to the interim order, SEBI alleged that REL misrepresented consolidated revenues aggregating to approximately Rs 15.15 lakh crore, representing 99.80 percent of the total consolidated revenue for the FY20-21 to FY24-25 period. The market watchdog also restrained Mehta from buying, selling, or dealing in Rajesh Exports Limited securities until further orders and directed a fresh forensic audit.

Rajesh Mehta, chairman and managing director at Rajesh Exports, has stated that there is no basis to SEBI's interim order, claiming that it is an interim order and nothing in it is true. The company is currently in the process of studying the order and will prepare a response.

Read also: ICICI Securities Maintains 'Hold' Rating, Targets Rs 4200

As a result of the interim order, shares of Rajesh Exports hit the lower circuit of 5 percent in early trade at Rs 103.92 on the National Stock Exchange (NSE).

PeriodTotal Consolidated RevenueMisrepresented Revenue
FY20-21 to FY24-25Rs 15.15 lakh crore (99.80%)

Note: The table represents the alleged misrepresented revenue by Rajesh Exports Ltd. as per SEBI's interim order.

Investor Takeaway

Investors should be cautious of potential regulatory issues affecting Rajesh Exports.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.